September 15: The Bid Is a Bucket, and It Has a Handle on It

Market regime

The quiet index, loud internals divide has now resolved in one direction. On 9/15 the average stock fell 0.82% with 989 advancers against 2,054 decliners, 61 names broke support versus 11 that broke resistance, and only 35% of the market still holds its 50-day. Long-term trend is not the problem — 65% of stocks remain in a golden-cross structure. It is the tactical line: average RSI 44, 296 names oversold, and 11 active chart patterns (triangles, channels) that have gone nowhere for weeks. This is a market grinding sideways to lower, punishing anyone who buys strength and paying only those who buy specific dislocations.

Mega forces

One — the inflation bid is structural, not cyclical. WTI is up 25% in a month and 115% in a year; broad commodities +11% and +54%. Oil has completely decoupled from equities (Energy is the only green sector, +5.3% on the month, 80% of constituents above their 50-day) while the average US sector is -2.4%. The 10-year at 4.63% with a steepening 51bp curve is the bond market's verdict on $85 crude plus a 3.63% policy rate. This is a capex and supply-constraint cycle, not a demand boom — and it is re-pricing the cost of capital for every long-duration asset.

Two — policy is now a two-way risk, and the crypto market just learned that. The CLARITY Act failed its Senate cloture vote, and crypto-linked equity (CRCL -11.4% today) reversed even as the underlying tokens remain the month's best performers. Regulation that was expected to arrive is not arriving — a reminder that duration and policy dependency, not earnings, set the price of the sector.

Three — the hardware/knowledge rotation is becoming a value trap in reverse. Semiconductor capital equipment -16% in a month, memory chips -14.7%, photonics -21.5%, Lidar -27%, while the names using the compute — Tempus AI, Caris, Revvity, Schrodinger, Fortrea — were among the day's biggest gainers. The market is moving from owning the tools to owning the output.

What's working

Energy in all its forms: E&Ps (+11% 1M), integrateds (+14%), royalties (+6.5%), and shipping (+7%). The trade is not just price — NOG trades at a 54% free-cash-flow yield, RRC and DVN at 12%+ with 84–94% gross margins. Oil companies are returning cash at prices that assume nothing heroic. Off-cycle health care remains the best two-way idea: Health Care is -2.7% over the month, but its 191 uptrending names are up 6.8% in 30 days and 34% in 90. Plus the day's session-level signals: Skyworks +13.6%, Qorvo +9.3% (analog semis, not the AI complex), and the acquisition tape (ACVA +44% on Copart's $1.9B takeout, ELMT +33% on a tungsten defense contract) reminding us deal risk premium is still being paid.

Strategy

Favor the supply-constrained end of the economy: energy producers with real FCF yields, marine transport, and the clinical/life-science developers where fundamentals are idiosyncratic rather than macro-driven. Avoid builders of industrial hardware into a capacity-guessing cycle — satellite, solar equipment, industrial storage and defense components are down 15–18% and still have no bid. And avoid long-duration, low-margin Industrials and Consumer Discretionary, with just 21% and 17% of constituents above their 50-day and -8.9%/-9.5% monthly returns. With 27% of stocks within 10% of 52-week highs versus 62% below their 50-day, the correct posture is selective accumulation into weakness, not index exposure.